Literature DB >> 2480905

P2-purinoceptor-mediated membrane currents in DDT1 MF-2 smooth muscle cells.

A Molleman1, A Nelemans, A Den Hertog.   

Abstract

The electrophysiological response evoked by ATP was investigated in the DDT1 MF-2 smooth muscle cell line using the microelectrode technique and the whole-cell patch clamp technique. Application of ATP (10(-3) M) to the bathing solution caused a small initial depolarization of the cell membrane, followed by hyperpolarization and slow depolarization. During voltage clamping (-50 mV) a triphasic response was recorded on stimulation with ATP (10(-4)-10(-3) M). A short-lasting inward current was followed by a transient outward current and a slowly decreasing inward current. This response was not affected by the receptor antagonists, propranolol (3 X 10(-6) M), phentolamine (3 X 10(-6) M), atropine (3 X 10(-6) M) or theophylline (10(-3) M). The ATP-induced currents were not modified by the voltage-dependent channel blocking agents, tetraethyl ammonium (3 X 10(-3) M), 3,4-diaminopyridine (10(-3) M), tetrodotoxin (3 X 10(-7) M) or diltiazem (10(-5) M). The fast inward current was not detectable at a low ATP concentration (10(-5) M). The outward current showed a reversal potential near -76 mV, which equals the potassium equilibrium potential. This current was abolished after neutralization of the potassium electrochemical gradient. The outward current was suppressed under calcium-free conditions and also in the presence of tolbutamide (10(-4) M) or glipizide (5 X 10(-6) M). Guanosine triphosphate (5 X 10(-6) M) promoted the outward current, while this current was inhibited in the presence of guanosine diphosphate (5 X 10(-6) M).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480905     DOI: 10.1016/0014-2999(89)90829-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line.

Authors:  M Begg; A Baydoun; M E Parsons; A Molleman
Journal:  J Physiol       Date:  2001-02-15       Impact factor: 5.182

2.  The nucleotide receptors on mouse C2C12 myotubes.

Authors:  R H Henning; A Nelemans; J van den Akker; A den Hertog
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

3.  Voltage-dependent sodium and potassium, but no calcium conductances in DDT1 MF-2 smooth muscle cells.

Authors:  A Molleman; A Nelemans; J van den Akker; M Duin; A den Hertog
Journal:  Pflugers Arch       Date:  1991-01       Impact factor: 3.657

4.  Characterization of the outward rectifying potassium channel in a novel mouse intestinal smooth muscle cell preparation.

Authors:  A Molleman; L Thuneberg; J D Huizinga
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

5.  Calcium release from separate receptor-specific intracellular stores induced by histamine and ATP in a hamster cell line.

Authors:  A Den Hertog; B Hoiting; A Molleman; J Van den Akker; M Duin; A Nelemans
Journal:  J Physiol       Date:  1992-08       Impact factor: 5.182

6.  Arachidonic acid is functioning as a second messenger in activating the Ca2+ entry process on H1-histaminoceptor stimulation in DDT1 MF-2 cells.

Authors:  L van der Zee; A Nelemans; A den Hertog
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

7.  Ca(2+)-dependent and -independent mechanism of cyclic-AMP reduction: mediation by bradykinin B2 receptors.

Authors:  H Sipma; A den Hertog; A Nelemans
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

8.  Possible mechanism of ciliary stimulation by extracellular ATP: involvement of calcium-dependent potassium channels and exogenous Ca2+.

Authors:  T Weiss; L Gheber; V Shoshan-Barmatz; Z Priel
Journal:  J Membr Biol       Date:  1992-05       Impact factor: 1.843

9.  Regulation of histamine- and UTP-induced increases in Ins(1,4,5)P3, Ins (1,3,4,5)P4 and Ca2+ by cyclic AMP in DDT1 MF-2 cells.

Authors:  H Sipma; M Duin; B Hoiting; A den Hertog; A Nelemans
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.